1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1016/s0885-3924(01)00258-5" target="_blank" rel="noreferrer">http://doi.org/10.1016/s0885-3924(01)00258-5</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Effects of high dose opioids and sedatives on survival in terminally ill cancer patients
Publisher
An entity responsible for making the resource available
Journal Of Pain And Symptom Management
Date
A point or period of time associated with an event in the lifecycle of the resource
2001
Subject
The topic of the resource
Female; Humans; Male; Palliative Care; Aged; Middle Aged; Survival Analysis; Inpatients; Forecasting; Dose-Response Relationship; Drug; Neoplasms/drug therapy; Critical Illness/therapy; Hypnotics and Sedatives/administration & dosage/adverse effects/therapeutic use; Narcotics/administration & dosage/adverse effects/therapeutic use
Creator
An entity primarily responsible for making the resource
Morita T; Tsunoda J; Inoue S; Chihara S
Description
An account of the resource
Concerns that high dose opioids and sedatives might shorten patient survival could contribute to insufficient symptom alleviation for terminally ill cancer patients. To examine the effects of opioids and sedatives prescribed in the final 48 hours on patient survival, a re-analysis of the prospectively collected data was performed on 209 hospice inpatients. Patient characteristics and clinical symptoms were prospectively recorded, and information about the use of opioids and sedatives in the last two days was collected by a chart review. Opioids were prescribed in 82% of the patients, with a median dose of 80 mg oral morphine equivalent (OME)/48 hours. Sixty percent received some sedative medications, mainly haloperidol (43% of total sample, 7.5 mg/48 hours), midazolam (23%, 23mg/48 hours), and hydroxyzine (15%, 50 mg/48 hours). There were no significant differences in survival between the patients who received different doses of opioids ( or =600 mg OME/48 hours) and of benzodiazepines (0, 1--59, and > or =60 mg parental midazolam equivalent/48 hours). Also, the survival of patients with haloperidol, hydroxyzine, and other sedative medications did not differ from those without. Furthermore, an addition of use of opioids and sedatives in the final 48 hours into the multiple regression model for survival prediction achieved no significant increase in predictability. In conclusion, opioids and sedatives used for symptom control in the last days are not associated with patient survival. They are safe and useful medications to palliate severe distress in the terminal stage of cancer when administered with a low initial dosage and adequate titration.
2001
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1016/s0885-3924(01)00258-5" target="_blank" rel="noreferrer">10.1016/s0885-3924(01)00258-5</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2001
Aged
Backlog
Chihara S
Critical Illness/therapy
Dose-Response Relationship
Drug
Female
Forecasting
Humans
Hypnotics and Sedatives/administration & dosage/adverse effects/therapeutic use
Inoue S
Inpatients
Journal Article
Journal of Pain and Symptom Management
Male
Middle Aged
Morita T
Narcotics/administration & dosage/adverse effects/therapeutic use
Neoplasms/drug therapy
Palliative Care
Survival Analysis
Tsunoda J